Stage II colon cancer patients face tough decisions about whether the possible benefits of chemotherapy outweigh its risks and challenges. This webinar from the Colorectal Cancer Coalition explored the answers with you.
Dr. John Marshall, Chief of the Division of Hematology/Oncology, Director of Development Therapeutics & GI Oncology, and Director of the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at the Georgetown Lombardi Comprehensive Cancer Center
Kim Ryan, Director of Patient Information Services, Colorectal Cancer Coalition
Kate Murphy, Director of Research Communication, Colorectal Cancer Coalition